ABELCET 100mg Infusion/Concentrate for

What is ABELCET 100mg

ABELCET 100mg is an antifungal medication formulated as an infusion concentrate containing amphotericin B in the form of a lipid complex. It is supplied in a 20ml vial and used primarily to treat severe systemic fungal infections.

• ABELCET contains amphotericin B as a lipid complex, which enhances drug delivery and reduces toxicity compared to conventional amphotericin B formulations.
• It is indicated for invasive fungal infections caused by susceptible fungi, including Candida species, Aspergillus species, and other rare fungal pathogens.
• This medication is particularly reserved for serious infections where oral antifungal agents are insufficient or ineffective.
• Lipid formulations of amphotericin B like ABELCET improve tolerability, especially minimizing nephrotoxicity, a major side effect of conventional amphotericin B.
• It is administered intravenously under strict medical supervision, typically in hospital settings.
• ABELCET is part of the polyene antifungal class and is essential in managing life-threatening fungal infections in immunocompromised patients such as those with cancer, HIV/AIDS, or post-transplantation.

In summary, ABELCET 100mg is a potent lipid-based amphotericin B formulation designed to provide effective antifungal therapy with reduced toxicity risks.

How to use ABELCET 100mg

ABELCET must be administered carefully to maximize efficacy and reduce adverse effects. The following guidelines apply:

• Preparation: Reconstitute the 20ml vial according to manufacturer instructions, typically diluting in appropriate infusion fluids such as 5% dextrose or normal saline.
• Administration Route: Administer by intravenous infusion only; do not give as an intravenous bolus or injection.
• Infusion Rate: Infuse slowly over 2 to 6 hours to reduce infusion-related reactions.
• Dosage Monitoring: Dose adjustments should be guided by clinical response and patient tolerance, with close monitoring of renal function and electrolytes.
• Premedication: Consider premedication with antipyretics, antihistamines, or corticosteroids to minimize infusion-related side effects such as fever, chills, or hypotension.
• Hydration: Maintain adequate hydration before and during therapy to help prevent nephrotoxicity.
• Medical Supervision: Use under strict hospital supervision with facilities for managing possible adverse effects.

Following these instructions helps ensure safe and effective use of ABELCET 100mg.

Mode of Action ABELCET 100mg

ABELCET contains amphotericin B formulated as a lipid complex, and its antifungal activity involves several mechanisms:

• Binding to Ergosterol: Amphotericin B binds selectively to ergosterol, a critical component of fungal cell membranes.
• Membrane Disruption: This binding creates pores in the fungal cell membrane, increasing membrane permeability and causing leakage of essential intracellular ions and molecules.
• Cell Death: The disruption of membrane integrity leads to fungal cell death through leakage of potassium, magnesium, and other vital ions.
• Lipid Complex Formulation: The lipid complex allows targeted delivery to fungal cells, enhancing uptake while reducing binding to human cholesterol-containing membranes, thus decreasing toxicity.
• Broad Spectrum: Effective against a wide range of pathogenic fungi including yeasts and molds.

This mechanism makes ABELCET a highly effective antifungal, especially for deep systemic infections.

ABELCET 100mg Interactions ABELCET 100mg

Drug interactions with ABELCET require careful consideration to avoid toxicity or reduced efficacy:

• Nephrotoxic Drugs: Concurrent use with other nephrotoxic agents (e.g., aminoglycosides, cyclosporine, NSAIDs) can increase risk of kidney damage.
• Electrolyte-altering Drugs: Drugs that affect potassium or magnesium levels (e.g., diuretics, corticosteroids) may exacerbate ABELCET-induced electrolyte disturbances.
• Immunosuppressants: Immunosuppressive therapies may alter infection risk and require dose adjustments.
• Other Antifungals: Combining with azoles may be synergistic but requires monitoring for additive toxicity.
• Warfarin: Amphotericin B can potentiate anticoagulant effects, requiring careful INR monitoring.
• Digitalis: Electrolyte imbalances induced by ABELCET may increase digitalis toxicity risk.

Always inform the healthcare provider of all medications to ensure safe combination therapy.

Dosage of ABELCET 100mg

Dosage of ABELCET must be individualized based on infection severity, patient condition, and tolerability:

• Standard Dose: Typically, 5 mg/kg/day administered as intravenous infusion over 2-6 hours.
• Duration: Treatment duration varies widely depending on clinical response and fungal pathogen, often ranging from 2 to 8 weeks or longer.
• Renal Impairment: Dose adjustments or extended dosing intervals may be necessary in patients with compromised kidney function.
• Monitoring: Frequent monitoring of renal function, electrolytes, and hematologic parameters is essential to guide therapy.
• Loading Dose: Usually not required due to the lipid formulation's pharmacokinetics.
• Infusion Rate: Slow infusion to minimize infusion-related reactions is mandatory.

Dosage must be prescribed and adjusted by a specialist experienced in managing systemic fungal infections.

Possible side effects of ABELCET 100mg

ABELCET is generally better tolerated than conventional amphotericin B but can still cause adverse effects:

• Infusion-related Reactions: Fever, chills, headache, nausea, vomiting, hypotension, and tachypnea during or shortly after infusion.
• Nephrotoxicity: Kidney impairment can occur, though less frequently than with conventional amphotericin B.
• Electrolyte Imbalances: Hypokalemia and hypomagnesemia are common and require monitoring.
• Hematologic Effects: Anemia, leukopenia, and thrombocytopenia may develop with prolonged therapy.
• Hepatotoxicity: Elevated liver enzymes and rare liver injury reported.
• Allergic Reactions: Rare anaphylactic or hypersensitivity reactions.
• Others: Malaise, muscle pain, and local infusion site reactions.

Early detection and management of side effects are critical for safe treatment continuation.

ABELCET 100mg Contraindications ABELCET 100mg

ABELCET is generally better tolerated than conventional amphotericin B but can still cause adverse effects:

• Infusion-related Reactions: Fever, chills, headache, nausea, vomiting, hypotension, and tachypnea during or shortly after infusion.
• Nephrotoxicity: Kidney impairment can occur, though less frequently than with conventional amphotericin B.
• Electrolyte Imbalances: Hypokalemia and hypomagnesemia are common and require monitoring.
• Hematologic Effects: Anemia, leukopenia, and thrombocytopenia may develop with prolonged therapy.
• Hepatotoxicity: Elevated liver enzymes and rare liver injury reported.
• Allergic Reactions: Rare anaphylactic or hypersensitivity reactions.
• Others: Malaise, muscle pain, and local infusion site reactions.

Early detection and management of side effects are critical for safe treatment continuation.

Storage of ABELCET 100mg

Proper storage of ABELCET ensures drug stability and safety:

• Store unopened vials at controlled room temperature, typically between 20°C and 25°C (68°F to 77°F).
• Protect from light by keeping the vial in its original carton until use.
• Do not freeze the product; discard if frozen.
• After reconstitution, use the prepared infusion promptly according to guidelines; do not store for prolonged periods.
• Keep out of reach of children and unauthorized personnel.

Adhering to storage recommendations preserves the efficacy and safety profile of ABELCET 100mg.